Search Results - Jonathan L. Curry

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    MonoMAC versus idiopathic CD4+ lymphocytopenia. Comment to Haematologica. 2011;96(8):1221–5 by Vicki H. Chu, Jonathan L. Curry, M. Tarek Elghetany, Choladda V. Curry

    Published in Haematologica (2012-04-01)
    Get full text
    Article


  2. 2

    Case Report: Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Case Series on the Clinical and Histopathologic Spectrum of Adverse Cutaneous Reactions From Fatal Stevens-Jo... by Paul V. Viscuse, Mario L. Marques-Piubelli, Meghan M. Heberton, Edwin Roger Parra, Amishi Y. Shah, Arlene Siefker-Radtke, Jianjun Gao, Sangeeta Goswami, Doina Ivan, Jonathan L. Curry, Jonathan L. Curry, Matthew T. Campbell

    Published in Frontiers in Oncology (2021-03-01)
    Get full text
    Article


  3. 3

    Plasma cell myeloma with immature plasma cells in the skin arising within the areas of chronic stasis dermatitis by Padmavathi Karri, BS, Benjamin Freemyer, MD, Nader Aboul-Fettouh, MD, Anisha B. Patel, MD, Jonathan L. Curry, MD, Megan Rogge, MD

    Published in JAAD Case Reports (2021-01-01)
    Get full text
    Article


  4. 4

    H3K79me3T80ph is a Novel Histone Dual Modification and a Mitotic Indicator in Melanoma by Danielle R. Martinez, Hunter W. Richards, Qiushi Lin, Carlos A. Torres-Cabala, Victor G. Prieto, Jonathan L. Curry, Estela E. Medrano

    Published in Journal of Skin Cancer (2012-01-01)
    Get full text
    Article


  5. 5

    Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors by Jonathan L Curry, Aung Naing, Joud Hajjar, Cara L Haymaker, Ken Chen, Dzifa Yawa Duose, Anisha B Patel, Omar Pacha, Nejla Ozirmak Lermi

    Published in Journal for ImmunoTherapy of Cancer (2025-08-01)
    Get full text
    Article


  6. 6

    Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma by Hanna Eriksson, Johan Hansson, Britta Krynitz, Giuseppe Masucci, Ada Girnita, Jan Lapins, Auris O. Huen, Hussein A. Tawbi, Michael A. Davies, Michael T. Tetzlaff, Jonathan L. Curry

    Published in Acta Dermato-Venereologica (2020-11-01)
    Get full text
    Article


  7. 7

    A case report of Grover’s disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1 by Patrick Hwu, Cara Haymaker, Chantale Bernatchez, Marc Uemura, Adi Diab, Natalie McQuail, Elizabeth Sirmans, Faisal Faˈak, Courtney W. Hudgens, Lydia Barbara, Jonathan L. Curry, Michael T. Tetzlaff

    Published in Journal for ImmunoTherapy of Cancer (2016-09-01)
    Get full text
    Article


  8. 8

    Molecular analysis of immune checkpoint inhibitor associated erythema nodosum-like toxicity by Xiaopeng Sun, Margaret L. Axelrod, Paula I. Gonzalez-Ericsson, Violeta Sanchez, Violeta Sanchez, Yu Wang, Jonathan L. Curry, Elizabeth J. Phillips, Yaomin Xu, Douglas B. Johnson, Justin M. Balko

    Published in Frontiers in Immunology (2025-03-01)
    Get full text
    Article


  9. 9

    TRPS1 expression in non-melanocytic cutaneous neoplasms: an immunohistochemical analysis of 200 cases by Yi A. Liu, Phyu P. Aung, Yunyi Wang, Jing Ning, Priyadharsini Nagarajan, Jonathan L. Curry, Carlos A. Torres-Cabala, Doina Ivan, Victor G. Prieto, Qingqing Ding, Woo Cheal Cho

    Get full text
    Article


  10. 10

    Programmed cell death ligand 1 expression in aggressive pediatric non-Hodgkin lymphomas: frequency, genetic mechanisms, and clinical significance by Kevin E. Fisher, Lizmery S. Ferguson, Amy M. Coffey, Brian Y. Merritt, Jonathan L. Curry, Andrea N. Marcogliese, Angela M. Major, Kala Y. Kamdar, Dolores H. Lopez-Terrada, Choladda V. Curry

    Published in Haematologica (2022-01-01)
    Get full text
    Article


  11. 11

    Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients by Michael T. Tetzlaff, Kelly C. Nelson, Adi Diab, Gregg A. Staerkel, Priyadharsini Nagarajan, Carlos A. Torres-Cabala, Beth A. Chasen, Jennifer A. Wargo, Victor G. Prieto, Rodabe N. Amaria, Jonathan L. Curry

    Published in Journal for ImmunoTherapy of Cancer (2018-02-01)
    Get full text
    Article


  12. 12

    Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma with novel FGFR1 fusion treated with pemigatinib by Carlos A. Torres-Cabala, Julia Arreola Yescas, Yue Zhang, Auris Huen, Gaur Sumit, Kristy Tefft, Guilin Tang, Jonathan L. Curry, Jillian Gunther, Bouthaina Dabaja, Swaminathan Iyer, Roberto N. Miranda, Jaehyuk Choi, Valentina Nardi

    Published in Blood Advances (2025-04-01)
    Get full text
    Article


  13. 13

    Systemic Toxicity With Hyperglycemia or Diabetic Ketoacidosis After Enfortumab Vedotin: Single-Center Case Series by Mohammad Jad Moussa, Nathaniel R. Wilson, Anindita Ghosh, Meenakshi B. Bhattacharjee, Jonathan L. Curry, Woo Cheal Cho, Anisha B. Patel, Mouhammed Amir Habra, Sonali N. Thosani, Matthew T. Campbell, Arlene O. Siefker-Radtke, Omar Alhalabi, Nupur J. Kikani

    Get full text
    Article


  14. 14

    Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis Fungoides by Mario L. Marques-Piubelli, Jesus Navarrete, Debora A. Ledesma, Courtney W. Hudgens, Rossana N. Lazcano, Ali Alani, Auris Huen, Madeleine Duvic, Priyadharsini Nagarajan, Phyu P. Aung, Ignacio I. Wistuba, Jonathan L. Curry, Roberto N. Miranda, Carlos A. Torres-Cabala

    Published in Cells (2024-02-01)
    Get full text
    Article


Search Tools: